Process Development & Manufacturing Technologies for Bio-therapeutics and Vaccines
03rd March 2021 | 3:00 PM India Standard Time/ 10:30 AM GMT | Atin Tomar, Co-Founder & CEO at Yapan Bio, Nirav Desai, Co-Founder at Yapan Bio |BOOK FREE SEAT FOR THIS WEBINAR
Presented by Atin Tomar, Co-Founder & CEO at Yapan Bio
Atin Tomar, is Co-Founder & CEO at Yapan Bio. Previously he was the president & CEO of CPL Biologicals, bringing with him comprehensive experience in the Biotechnology (Vaccines and Biologics) industry, globally. Atin’s experience and expertise spans from Process Development, Technology Transfer and Manufacturing Operations to Business Development, Licensing and Commercialization. Prior to CPL Biologicals, Atin was associated with the Biotechnology industry in various roles. He was involved in the development of Biologics/Bio-therapeutics from the early stages of development to commercial manufacturing at Human Genome Sciences Inc., Amgen Inc. and Syngene International (A Biocon Company). At Dr. Reddy’s Laboratories Ltd., MSD Wellcome Trust Hilleman Laboratories and International Vaccine Institute (IVI) Atin served in Business Development & Licensing, Program Management and Alliance (partnerships & collaborations) Management roles.
And Nirav Desai, Co-Founder at Yapan Bio
Nirav Desai is the Co-founder Yapan Bio LLP, founder 2019. Previously Nirav was Vice-President (Head R&D) at CPL Biologicals (JV between Cadila Pharma and Novavax, USA) till April 2019. Nirav has 20 years of experience in advancing Vaccines, Biologics and Diagnostic from PoC to commercialization. He has a proven track record for innovations, process and method development, tech transfer, facility start-up as well as experience of CRAMS management with international clients worth >10 m USD. Nirav has also successfully developed multiple products for commercialization